Virtus ETFs > ETFis Series Trust I
Virtus LifeSci Biotech Clinical Trials ETF
$12.91M
Avg Monthly Net Assets
$12.43M
Total Assets
$883K
Total Liabilities
$11.54M
Net Assets
Virtus LifeSci Biotech Clinical Trials ETF is an Exchange-Traded Fund in ETFis Series Trust I
from Virtus ETFs,
based in New York,
United States of America.
The fund has one share class
and monthly net assets of $12.91M.
On September 27th, 2024 it reported 122 holdings, the largest
being DREYFUS GOVERNMENT CASH MANAGE (7.6%), Morphic Holding Inc (1.6%) and Longboard Pharmaceuticals Inc (1.3%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| Virtus LifeSci Biotech Clinical Trials ETF | C000148681 | ARCX | BBC |
Holdings
From latest NPORT-P, filed September 27th, 2024 for period ending July 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics Inc | Long | Equity-common | US | $66K | 4K | 0.57 |
| 89bio Inc | Long | Equity-common | US | $89K | 10K | 0.77 |
| AbCellera Biologics Inc | Long | Equity-common | CA | $89K | 27K | 0.77 |
| ACELYRIN Inc | Long | Equity-common | US | $125K | 21K | 1.08 |
| Aerovate Therapeutics Inc | Long | Equity-common | US | $7K | 4K | 0.06 |
| Agenus Inc | Long | Equity-common | US | $34K | 6K | 0.30 |
| Akero Therapeutics Inc | Long | Equity-common | US | $98K | 4K | 0.85 |
| Alector Inc | Long | Equity-common | US | $110K | 18K | 0.95 |
| Allogene Therapeutics Inc | Long | Equity-common | US | $105K | 36K | 0.91 |
| ALX Oncology Holdings Inc | Long | Equity-common | US | $51K | 11K | 0.45 |
| AnaptysBio Inc | Long | Equity-common | US | $130K | 4K | 1.13 |
| Annexon Inc | Long | Equity-common | US | $97K | 15K | 0.84 |
| Apogee Therapeutics Inc | Long | Equity-common | US | $102K | 2K | 0.89 |
| Applied Therapeutics Inc | Long | Equity-common | US | $102K | 17K | 0.89 |
| Arbutus Biopharma Corp | Long | Equity-common | US | $108K | 29K | 0.94 |
| Arcellx Inc | Long | Equity-common | US | $100K | 2K | 0.87 |
| Arcturus Therapeutics Holdings Inc | Long | Equity-common | US | $67K | 3K | 0.58 |
| Arcus Biosciences Inc | Long | Equity-common | US | $87K | 5K | 0.76 |
| Arcutis Biotherapeutics Inc | Long | Equity-common | US | $98K | 10K | 0.85 |
| Arrowhead Pharmaceuticals Inc | Long | Equity-common | US | $98K | 3K | 0.85 |
| Arvinas Inc | Long | Equity-common | US | $94K | 3K | 0.82 |
| Autolus Therapeutics PLC | Long | Equity-common | GB | $94K | 20K | 0.81 |
| Avidity Biosciences Inc | Long | Equity-common | US | $103K | 2K | 0.89 |
| Beam Therapeutics Inc | Long | Equity-common | US | $113K | 4K | 0.98 |
| Belite Bio Inc | Long | Equity-common | US | $89K | 2K | 0.77 |
| Bicycle Therapeutics PLC | Long | Equity-common | GB | $91K | 4K | 0.78 |
| Biohaven Ltd | Long | Equity-common | US | $107K | 3K | 0.92 |
| Cabaletta Bio Inc | Long | Equity-common | US | $51K | 7K | 0.44 |
| Cargo Therapeutics Inc | Long | Equity-common | US | $90K | 5K | 0.78 |
| Cassava Sciences Inc | Long | Equity-common | US | $101K | 5K | 0.88 |
| Celcuity Inc | Long | Equity-common | US | $108K | 6K | 0.94 |
| Celldex Therapeutics Inc | Long | Equity-common | US | $95K | 2K | 0.82 |
| Centessa Pharmaceuticals PLC | Long | Equity-common | US | $96K | 9K | 0.83 |
| CG oncology Inc | Long | Equity-common | US | $87K | 3K | 0.75 |
| Cogent Biosciences Inc | Long | Equity-common | US | $95K | 10K | 0.82 |
| Compass Pathways Plc | Long | Equity-common | GB | $100K | 13K | 0.86 |
| Crinetics Pharmaceuticals Inc | Long | Equity-common | US | $103K | 2K | 0.89 |
| Cullinan Therapeutics Inc | Long | Equity-common | US | $80K | 4K | 0.70 |
| CureVac NV | Long | Equity-common | DE | $85K | 23K | 0.74 |
| Cytokinetics Inc | Long | Equity-common | US | $101K | 2K | 0.88 |
| Denali Therapeutics Inc | Long | Equity-common | US | $100K | 4K | 0.86 |
| Dianthus Therapeutics Inc | Long | Equity-common | US | $100K | 3K | 0.87 |
| Disc Medicine Inc | Long | Equity-common | US | $100K | 2K | 0.86 |
| DREYFUS GOVERNMENT CASH MANAGE | Long | Short-term investment vehicle | US | $876K | 876K | 7.58 |
| Dyne Therapeutics Inc | Long | Equity-common | US | $115K | 3K | 1.00 |
| Edgewise Therapeutics Inc | Long | Equity-common | US | $86K | 5K | 0.75 |
| Editas Medicine Inc | Long | Equity-common | US | $89K | 16K | 0.77 |
| Enliven Therapeutics Inc | Long | Equity-common | US | $108K | 4K | 0.94 |
| Erasca Inc | Long | Equity-common | US | $131K | 42K | 1.13 |
| Exscientia Plc | Long | Equity-common | GB | $101K | 19K | 0.87 |
| Fulcrum Therapeutics Inc | Long | Equity-common | US | $108K | 12K | 0.93 |
| HilleVax Inc | Long | Equity-common | US | $11K | 6K | 0.10 |
| Ideaya Biosciences Inc | Long | Equity-common | US | $100K | 2K | 0.87 |
| IGM Biosciences Inc | Long | Equity-common | US | $127K | 11K | 1.10 |
| Immatics NV | Long | Equity-common | DE | $84K | 7K | 0.73 |
| Immunome Inc | Long | Equity-common | US | $87K | 6K | 0.75 |
| Immunovant Inc | Long | Equity-common | US | $99K | 3K | 0.86 |
| Intellia Therapeutics Inc | Long | Equity-common | US | $91K | 3K | 0.79 |
| iTeos Therapeutics Inc | Long | Equity-common | US | $98K | 6K | 0.85 |
| Janux Therapeutics Inc | Long | Equity-common | US | $87K | 2K | 0.75 |
| Keros Therapeutics Inc | Long | Equity-common | US | $92K | 2K | 0.79 |
| Kura Oncology Inc | Long | Equity-common | US | $87K | 4K | 0.76 |
| Kymera Therapeutics Inc | Long | Equity-common | US | $120K | 3K | 1.04 |
| Kyverna Therapeutics Inc | Long | Equity-common | US | $54K | 6K | 0.47 |
| Larimar Therapeutics Inc | Long | Equity-common | US | $78K | 9K | 0.68 |
| Liquidia Corp | Long | Equity-common | US | $80K | 7K | 0.70 |
| Longboard Pharmaceuticals Inc | Long | Equity-common | US | $151K | 5K | 1.31 |
| Lyell Immunopharma Inc | Long | Equity-common | US | $56K | 35K | 0.49 |
| MacroGenics Inc | Long | Equity-common | US | $73K | 19K | 0.63 |
| Merus NV | Long | Equity-common | NL | $83K | 2K | 0.72 |
| Mineralys Therapeutics Inc | Long | Equity-common | US | $88K | 7K | 0.77 |
| MoonLake Immunotherapeutics | Long | Equity-common | CH | $88K | 2K | 0.76 |
| Morphic Holding Inc | Long | Equity-common | US | $185K | 3K | 1.60 |
| Neumora Therapeutics Inc | Long | Equity-common | US | $117K | 9K | 1.01 |
| Neurogene Inc | Long | Equity-common | US | $89K | 2K | 0.77 |
| NEWAMSTERDAM PHARMA CO NV-27 | Long | Equity-common | NL | $80K | 5K | 0.69 |
| Nurix Therapeutics Inc | Long | Equity-common | US | $118K | 5K | 1.03 |
| Nuvalent Inc | Long | Equity-common | US | $92K | 1K | 0.79 |
| Nuvation Bio Inc | Long | Equity-common | US | $116K | 30K | 1.00 |
| Olema Pharmaceuticals Inc | Long | Equity-common | US | $117K | 7K | 1.02 |
| ORIC Pharmaceuticals Inc | Long | Equity-common | US | $132K | 12K | 1.14 |
| Perspective Therapeutics Inc | Long | Equity-common | US | $106K | 8K | 0.92 |
| Pharvaris NV | Long | Equity-common | NL | $86K | 5K | 0.74 |
| Pliant Therapeutics Inc | Long | Equity-common | US | $108K | 8K | 0.94 |
| Praxis Precision Medicines Inc | Long | Equity-common | US | $130K | 2K | 1.13 |
| Precigen Inc | Long | Equity-common | US | $81K | 53K | 0.70 |
| Prime Medicine Inc | Long | Equity-common | US | $64K | 11K | 0.56 |
| Protagonist Therapeutics Inc | Long | Equity-common | US | $99K | 3K | 0.85 |
| Prothena Corp PLC | Long | Equity-common | IE | $99K | 4K | 0.85 |
| Recursion Pharmaceuticals Inc | Long | Equity-common | US | $79K | 10K | 0.68 |
| REGENXBIO Inc | Long | Equity-common | US | $99K | 7K | 0.85 |
| Relay Therapeutics Inc | Long | Equity-common | US | $95K | 12K | 0.82 |
| Replimune Group Inc | Long | Equity-common | US | $96K | 10K | 0.83 |
| REVOLUTION Medicines Inc | Long | Equity-common | US | $104K | 2K | 0.90 |
| Rocket Pharmaceuticals Inc | Long | Equity-common | US | $96K | 4K | 0.83 |
| Sana Biotechnology Inc | Long | Equity-common | US | $77K | 13K | 0.67 |
| Savara Inc | Long | Equity-common | US | $103K | 22K | 0.89 |
| Scholar Rock Holding Corp | Long | Equity-common | US | $87K | 10K | 0.76 |
| Scilex Holding Co | Long | Equity-common | US | $25K | 18K | 0.22 |
| Silence Therapeutics PLC | Long | Equity-common | GB | $94K | 5K | 0.82 |
| Soleno Therapeutics Inc | Long | Equity-common | US | $97K | 2K | 0.84 |
| Spyre Therapeutics Inc | Long | Equity-common | US | $77K | 3K | 0.67 |
| Stoke Therapeutics Inc | Long | Equity-common | US | $77K | 5K | 0.67 |
| Structure Therapeutics Inc | Long | Equity-common | US | $66K | 2K | 0.57 |
| Summit Therapeutics Inc | Long | Equity-common | US | $121K | 11K | 1.05 |
| Syndax Pharmaceuticals Inc | Long | Equity-common | US | $99K | 4K | 0.86 |
| Tango Therapeutics Inc | Long | Equity-common | US | $106K | 11K | 0.92 |
| Taysha Gene Therapies Inc | Long | Equity-common | US | $48K | 22K | 0.42 |
| Terns Pharmaceuticals Inc | Long | Equity-common | US | $88K | 11K | 0.76 |
| Tyra Biosciences Inc | Long | Equity-common | US | $101K | 5K | 0.88 |
| uniQure NV | Long | Equity-common | NL | $132K | 17K | 1.14 |
| Vaxcyte Inc | Long | Equity-common | US | $96K | 1K | 0.84 |
| Vera Therapeutics Inc | Long | Equity-common | US | $89K | 2K | 0.77 |
| Verve Therapeutics Inc | Long | Equity-common | US | $113K | 16K | 0.98 |
| Viking Therapeutics Inc | Long | Equity-common | US | $99K | 2K | 0.86 |
| Vir Biotechnology Inc | Long | Equity-common | US | $89K | 9K | 0.77 |
| Viridian Therapeutics Inc | Long | Equity-common | US | $116K | 7K | 1.00 |
| WaVe Life Sciences Ltd | Long | Equity-common | US | $92K | 14K | 0.80 |
| Xencor Inc | Long | Equity-common | US | $87K | 4K | 0.75 |
| Xenon Pharmaceuticals Inc | Long | Equity-common | CA | $103K | 2K | 0.89 |
| Zentalis Pharmaceuticals Inc | Long | Equity-common | US | $37K | 10K | 0.32 |
| Zymeworks Inc | Long | Equity-common | US | $104K | 10K | 0.90 |
Address
ETFis Series Trust I
31 West 52nd Street
16th Floor
New York
New York
10019
United States of America
Websites
Directors
Robert S. Tull, Jr.
William J. Smalley
Myles J. Edwards
James A. Simpson
Transfer Agents
The Bank of New York Mellon
Pricing Services
ICE Data Services, Inc.
Bloomberg L.P.
Refinitiv US Holdings Inc.
Custodians
Joint Stock Company Commercial Bank Citibank
The Bank of New York Mellon
The Depository Trust Company
Federal Reserve Bank of New York
Shareholder Servicing Agents
The Bank of New York Mellon
Admins
The Bank of New York Mellon
Virtus ETF Solutions LLC
Brokers
VIRTU AMERICAS LLC
Jane Street Execution Services, LLC